This is a routine portfolio adjustment by an institutional fund manager. No material impact on ELVN's stock expected. Monitor for any larger insider selling patterns or changes in OrbiMed's disclosed holdings in future 13F filings.
Price Chart
Executive Summary
OrbiMed Capital LLC, acting as portfolio manager for The Biotech Growth Trust PLC, filed a Form 144 notice of intent to sell 10,243 shares of Enliven Therapeutics (ELVN) common stock, valued at approximately $433,893. The shares were acquired via merger in February 2023. This is a routine, small-scale sale by an institutional fund and carries no material signal for the stock.
Key Facts
- OrbiMed Capital LLC (on behalf of The Biotech Growth Trust PLC) filed Form 144 to sell 10,243 shares of ELVN common stock.
- Estimated sale value: approximately $433,893.
- Shares were acquired on 02/23/2023 via merger (from IMARA Inc.).
- Sale is to be executed through Themis Trading LLC on the Nasdaq.
- Filing date: June 15, 2026.
Financial Impact
Sale of ~$434K represents less than 0.02% of ELVN's $2.8B market cap — negligible.
Risk Factors
- None material from this filing; the sale is small and from an institutional affiliate, not a corporate insider.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0000947871-26-000629 |
| Document: 0000947871-26-000629-index.html | 0000947871-26-000629 |
| Document: 0000947871-26-000629.txt | 0000947871-26-000629 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | Insider Cluster | $41.93 | awaiting T+5 | — | $41.52 (−0.98%) |
Oct 19, 2026 7d ago | 144 | $41.25 | awaiting T+5 | — | $41.52 (+0.65%) |
Oct 16, 2026 10d ago | 3 | $38.70 $41.49 | ▲ +7.21% | ▲ +7.35% | $41.52 (+7.29%) |
Oct 14, 2026 12d ago | 8-K | $39.33 $41.93 | ▲ +6.61% | ▲ +7.63% | $41.52 (+5.57%) |
Sep 21, 2026 5w ago | Insider Cluster | $48.19 $46.51 | ▼ −3.49% | ▼ −2.30% | $41.52 (−13.84%) |
Sep 4, 2026 7w ago | 144 | $59.32 $54.43 | ▼ −8.24% | ▼ −7.03% | $41.52 (−30.01%) |
Aug 19, 2026 9w ago | Insider Cluster | $58.97 $60.50 | ▲ +2.59% | ▲ +1.48% | $41.52 (−29.59%) |
Aug 9, 2026 11w ago | Institutional Cluster | $59.42 $59.54 | ▲ +0.19% | ▲ +0.24% | $41.52 (−30.12%) |
Jul 21, 2026 13w ago | Insider Cluster | $52.85 $52.97 | ▲ +0.23% | ▲ +2.63% | $41.52 (−21.44%) |
Jun 22, 2026 18w ago | 144 | $48.60 $50.85 | ▲ +4.63% | ▲ +3.62% | $41.52 (−14.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers